These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 16033773)
1. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter. Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773 [TBL] [Abstract][Full Text] [Related]
3. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Alemayehu A; Sebova K; Fridrichova I Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic signatures of familial cancer are characteristic of tumor type and family category. Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504 [TBL] [Abstract][Full Text] [Related]
5. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
6. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982 [TBL] [Abstract][Full Text] [Related]
7. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Koinuma K; Yamashita Y; Liu W; Hatanaka H; Kurashina K; Wada T; Takada S; Kaneda R; Choi YL; Fujiwara SI; Miyakura Y; Nagai H; Mano H Oncogene; 2006 Jan; 25(1):139-46. PubMed ID: 16247484 [TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer. Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R J BUON; 2011; 16(2):265-73. PubMed ID: 21766496 [TBL] [Abstract][Full Text] [Related]
11. The dynamic DNA methylation landscape of the Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327 [TBL] [Abstract][Full Text] [Related]
12. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas. Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843 [TBL] [Abstract][Full Text] [Related]
13. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Lawes DA; Pearson T; Sengupta S; Boulos PB Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253 [TBL] [Abstract][Full Text] [Related]
14. Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones. Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H J Surg Oncol; 2007 Dec; 96(7):611-8. PubMed ID: 17786961 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853 [TBL] [Abstract][Full Text] [Related]
16. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma. Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042 [TBL] [Abstract][Full Text] [Related]
18. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609 [TBL] [Abstract][Full Text] [Related]
19. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability. Kang GH; Lee S; Shim YH; Kim JC; Ro JY Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445 [TBL] [Abstract][Full Text] [Related]
20. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis. Miyakura Y; Sugano K; Konishi F; Fukayama N; Igarashi S; Kotake K; Matsui T; Koyama Y; Maekawa M; Nagai H Genes Chromosomes Cancer; 2003 Jan; 36(1):17-25. PubMed ID: 12461746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]